INN | andere nicht geschützte oder Trivialnamen | chemische Namen (IUPAC) |
– | AB-CHMINACA | N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazol-3-carboxamid |
– | AB-FUBINACA | N-(1-Amino-3-methyl-1-oxobutan- 2-yl)-1-[(4-fluorphenyl)methyl]-1H-indazol-3-carboxamid |
– | AB-PINACA | N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazol-3-carboxamid |
- | Acetylfentanyl (Desmethylfentanyl) | N-Phenyl-N-[1-(2-phenylethyl) piperidin-4-yl]acetamid |
- | Acryloylfentanyl (Acrylfentanyl, ACF) | N-Phenyl-N-[1-(2-phenylethyl) piperidin-4-yl]prop-3-enamid |
– | 1-Adamantyl (1-pentyl-1H-indol-3-yl)methanon | (Adamantan-1-yl)(1-pentyl-1H-indol- 3-yl)methanon |
– | Brorphin | 1-{1-[1-(4-Bromphenyl)ethyl]piperidin-4-yl}-1,3-dihydro-2Hbenzimidazol-2-on |
– | 3-Chlormethcathinon (3-CMC, Clophedron) | 1-(3-Chlorphenyl)-2-methylaminopropan-1-on |
– | ADB-BINACA (ADB-BUTINACA, ADMB-BINACA) | N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl-1H-indazol-3-carboxamid |
– | ADB-CHMINACA (MAB-CHMINACA) |
N-(1-Amino-3,3-dimethyl-1- oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazol-3-carboxamid |
– | ADB-FUBINACA | N-(1-Amino-3,3-dimethyl-1- oxobutan-2-yl)-1-[(4-fluorphenyl) methyl]-1H-indazol-3-carboxamid |
– | AH-7921 (Doxylam) |
3,4-Dichlor-N-{[1-(dimethylamino)cyclohexyl]methyl}benzamid |
– | AKB-48 (APINACA) |
N-(Adamantan-1-yl)-1-pentyl-1H-indazol-3-carboxamid |
– | AKB-48F | N-(Adamantan-1-yl)-1-(5-fluorpentyl)- 1H-indazol-3-carboxamid |
– | α-Pyrrolidinoisohexanophenon (Alpha-PiHP, α-PiHP, 4-Methyl-α-PVP) | 4-Methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-on |
– | Alpha-PVT (α-PVT, alpha-Pyrrolidinopentiothiophenon) | 2-(Pyrrolidin-1-yl)-1-(thiophen-2-yl)pentan-1-on |
– | AM-694 | [1-(5-Fluorpentyl)-1H-indol-3-yl](2- iodphenyl)methanon |
– | AM-1220 | {1-[(1-Methylpiperidin-2-yl)methyl]-1H-indol-3-yl}(naphthalin-1-yl) methanon |
– | AM-1220-Azepan | [1-(1-Methylazepan-3-yl)-1H-indol-3-yl](naphthalin-1-yl)methanon |
– | AM-2201 | [1-(5-Fluorpentyl)-1H-indol-3-yl](naphthalin-1-yl)methanon |
– | AM-2232 | 5-[3-(Naphthalin-1-carbonyl)-1H-indol-1-yl]pentannitril |
– | AM-2233 | (2-Iodphenyl){1-[(1-methylpiperidin-2-yl)methyl]-1H-indol-3-yl}methanon |
– | AMB-CHMICA (MMB-CHMICA) | Methyl{2-[1-(cyclohexylmethyl)-1H-indol-3-carboxamido]-3-methylbutanoat} |
– | AMB-FUBINACA (FUB-AMB) |
Methyl(2-{1-[(4-fluorphenyl)methyl]- 1H-indazol-3-carboxamid}-3-methylbutanoat) |
Amfetaminil | – | (Phenyl)[(1-phenylpropan-2-yl)amino]acetonitril |
Amineptin | – | 7-(10,11-Dihydro-5H-dibenzo[a,d][7]annulen-5-ylamino)heptansäure |
Aminorex | – | 5-Phenyl-4,5-dihydro-1,3-oxazol-2-ylazan |
– | 5-APB | 1-(Benzofuran-5-yl)propan-2-amin |
– | 6-APB | 1-(Benzofuran-6-yl)propan-2-amin |
– | APICA (SDB-001, 2NE1) |
N-(Adamantan-1-yl)-1-pentyl-1H-indol-3-carboxamid |
– | BB-22 (QUCHIC) |
Chinolin-8-yl[1-(cyclohexylmethyl)-1H-indol-3-carboxylat] |
– | Benzylpiperazin (BZP) |
1-Benzylpiperazin |
– | Buphedron | 2-(Methylamino)-1-phenylbutan-1-on |
Butalbital | – | 5-Allyl-5-isobutylbarbitursäure |
– | Butobarbital | 5-Butyl-5-ethylpyrimidin-2,4,6(1H,3H,5H)-trion |
– | Butylon | 1-(Benzo[d][1,3]dioxol-5-yl)-2- (methylamino)butan-1-on |
– | Butyrfentanyl (Butyrylfentanyl) | N-Phenyl-N-[1-(2-phenylethyl) piperidin-4-yl]butanamid |
Cetobemidon | Ketobemidon | 1-[4-(3-Hydroxyphenyl)-1-methyl-4-piperidyl]propan-1-on |
– | meta-Chlorphenylpiperazin (m-CPP) | 1-(3-Chlorphenyl)piperazin |
– | 5Cl-AKB-48 (5C-AKB-48, AKB-48Cl, 5CI-APINACA, 5C-APINACA) | N-(Adamantan-1-yl)-1-(5- chlorpentyl)-1H-indazol-3-carboxamid |
– | 5Cl-JWH-018 (JWH-018 N-(5-Chlorpentyl)- Analogon) | [1-(5-Chlorpentyl)-1H-indol-3-yl] (naphthalin-1-yl)methanon |
– | d-Cocain | Methyl[3β-(benzoyloxy)tropan-2α-carboxylat] |
- | CP 47,497 (cis-3-[4-(1,1-Dimethylheptyl)-2- hydroxyphenyl]-cyclohexanol) | 5-(1,1-Dimethylheptyl)-2- [(1RS,3SR)-3-hydroxycyclohexyl]- phenol |
- | CP 47,497-C6-Homolog (cis-3-[4-(1,1-Dimethylhexyl)-2- hydroxyphenyl]-cyclohexanol) | 5-(1,1-Dimethylhexyl)-2- [(1RS,3SR)-3-hydroxycyclohexyl]- phenol |
- | CP 47,497-C8-Homolog (cis-3-[4-(1,1-Dimethyloctyl)-2- hydroxyphenyl]-cyclohexanol) | 5-(1,1-Dimethyloctyl)-2- [(1RS,3SR)-3-hydroxycyclohexyl]- phenol |
- | CP 47,497-C9-Homolog (cis-3-[4-(1,1-Dimethylnonyl)- 2-hydroxyphenyl]-cyclohexanol) | 5-(1,1-Dimethylnonyl)-2- [(1RS,3SR)-3-hydroxycyclohexyl]- phenol |
- | Crotonylfentanyl | (2E)-N-Phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]but-2-enamid |
- | CUMYL-PEGACLONE (SGT-151) | 5-Pentyl-2-(2-phenylpropan-2-yl)-2,5-dihydro-1H-pyrido[4,3-b]indol-1-on |
- | CUMYL-4CN-BINACA[2] (SGT-78) | 1-(4-Cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazol-3-carboxamid |
- | CUMYL-5F-P7AICA (5-Fluor-CUMYL-P7AICA, SGT-263) | 1-(5-Fluorpentyl)-N-(2-phenylpropan-2-yl)- 1H-pyrrolo[2,3-b]pyridin-3-carboxamid |
- | CUMYL-5F-PEGACLONE (5F-Cumyl-PeGaClone, 5F-SGT-151) | 5-(5-Fluorpentyl)-2-(2-phenylpropan-2-yl)-2,5-dihydro-1H-pyrido[4,3-b]indol-1-on |
Cyclobarbital | – | 5-(Cyclohex-1-en-1-yl)-5-ethylpyrimidin-2,4,6(1H,3H,5H)-trion |
– | Cyclopropylfentanyl[3] | N-Phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropancarboxamid |
– | Desoxypipradrol (2-DPMP) |
2-(Diphenylmethyl)piperidin |
– | Dextromethadon | (S)-6-Dimethylamino-4,4-diphenylheptan-3-on |
Dextromoramid | – | (S)-3-Methyl-4-morpholino-2,2-diphenyl-1-(pyrrolidin-1-yl)butan-1-on |
Dextropropoxyphen | – | [(2S,3R)-4-Dimethylamino-3-methyl-1,2-... |
Dieser Inhalt ist unter anderem im Deutsches Anwalt Office Premium enthalten. Sie wollen mehr?
Jetzt kostenlos 4 Wochen testen